SCHEMBL4908598

SCHEMBL4908598

CCN(Oc1ccc(C(C)(C)C)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 1/20 0.38
MMP13 P45452 1/20 0.38
NR1H4 Q96RI1 3/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
HCRTR2 O43614 1/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PTPN5 P54829 1/20 0.35
POLB P06746 2/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.35
ATM Q13315 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HCAR2 Q8TDS4 1/20 0.35
MCL1 Q07820 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4901009 0.90 HDAC8 (0.37) ALDH1A1KDM4EHPGDHSD17B10RXRB
SCHEMBL4904415 0.89 ALDH1A1 (0.40) MMP9MMP13ALDH1A1KDM4EMEN1
SCHEMBL4906110 0.88 POLB (0.43) MMP9MMP13NR1H4AKR1C3AKR1C2
SCHEMBL4904268 0.86 HCRTR2 (0.41) ALDH1A1KDM4EMEN1KMT2AHCRTR2
SCHEMBL4906931 0.83 PTPN5 (0.38) MMP9MMP13AKR1C3AKR1C2ALDH1A1
SCHEMBL4903874 0.80 ALDH1A1 (0.39) MMP9MMP13ALDH1A1KDM4ESMN1; SMN2
SCHEMBL4902618 0.80 ALDH1A1 (0.46) MMP9MMP13ALDH1A1KDM4EMEN1
SCHEMBL4905612 0.78 NR1H4 (0.36) NR1H4ALDH1A1KDM4EMEN1KMT2A
SCHEMBL4901791 0.77 ALDH1A1 (0.42) MMP9ALDH1A1KDM4EMEN1KMT2A
SCHEMBL4906234 0.75 ALDH1A1 (0.46) MMP9MMP13NR1H4ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD MMP9 4666/4885MMP13 3379/4885NR1H4 20/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MMP9 4632/4885MMP13 3079/4885NR1H4 21/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MMP9 4632/4885MMP13 3079/4885NR1H4 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.